BlackRock’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $748M | Sell |
|
|||||
|
2022
Q2 | $739M | Buy |
|
|||||
|
2022
Q1 | $552M | Buy |
|
|||||
|
2021
Q4 | $639M | Buy |
|
|||||
|
2021
Q3 | $640M | Sell |
|
|||||
|
2021
Q2 | $455M | Buy |
|
|||||
|
2021
Q1 | $259M | Buy |
|
|||||
|
2020
Q4 | $302M | Buy |
|
|||||
|
2020
Q3 | $224M | Sell |
|
|||||
|
2020
Q2 | $258M | Buy |
|
|||||
|
2020
Q1 | $111M | Buy |
|
|||||
|
2019
Q4 | $159M | Buy |
|
|||||
|
2019
Q3 | $121M | Buy |
|
|||||
|
2019
Q2 | $109M | Sell |
|
|||||
|
2019
Q1 | $147M | Buy |
|
|||||
|
2018
Q4 | $88.5M | Buy |
|
|||||
|
2018
Q3 | $81.4M | Buy |
|
|||||
|
2018
Q2 | $82.6M | Buy |
|
|||||
|
2018
Q1 | $48.6M | Buy |
|
|||||
|
2017
Q4 | $31.1M | Buy |
|
|||||
|
2017
Q3 | $42.7M | Buy |
|
|||||
|
2017
Q2 | $25.5M | Buy |
|